Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 25 records, 3 pages
Search For: Conjugate Vaccine
Global Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Conjugate Vaccine market size was valued at USD 10280 million in 2023 and is forecast to a readjusted size of USD 12700 million by 2030 with a CAGR of 3.1% during review period.
USD3480.00
Add To Cart
Global Pneumococcal Conjugate Vaccine (PCV) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
15 Jan 2024
Pharma & Healthcare
Pneumococcal Conjugate Vaccine (PCV)
According to our (Global Info Research) latest study, the global Pneumococcal Conjugate Vaccine (PCV) market size was valued at USD 4257.8 million in 2023 and is forecast to a readjusted size of USD 5258.8 million by 2030 with a CAGR of 3.1% during review period.
USD3480.00
Add To Cart
Global Haemophilus b Conjugate Vaccine (Hib) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
20 Jan 2024
Pharma & Healthcare
Haemophilus b Conjugate Vaccine (Hib)
According to our (Global Info Research) latest study, the global Haemophilus b Conjugate Vaccine (Hib) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Pneumococcal 13-valent Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
28 Oct 2024
Pharma & Healthcare
Pneumococcal 13-valent Conjugate Vaccine
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
USD3480.00
Add To Cart
Global Pneumococcal 13-valent Conjugate Vaccine Supply, Demand and Key Producers, 2024-2030
28 Oct 2024
Pharma & Healthcare
Pneumococcal 13-valent Conjugate Vaccine
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
USD4480.00
Add To Cart
Global 13-Valent Pneumococcal Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
19 Jan 2024
Pharma & Healthcare
13-Valent Pneumococcal Conjugate Vaccine
According to our (Global Info Research) latest study, the global 13-Valent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Multivalent Pneumococcal Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
18 Jan 2024
Pharma & Healthcare
Multivalent Pneumococcal Conjugate Vaccine
According to our (Global Info Research) latest study, the global Multivalent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Meningococcal Group A and C Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
01 Jul 2024
Pharma & Healthcare
Meningococcal Group A and C Conjugate Vaccine
According to our (Global Info Research) latest study, the global Meningococcal Group A and C Conjugate Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
USD3480.00
Add To Cart
Global Meningococcal Group A and C Conjugate Vaccine Supply, Demand and Key Producers, 2024-2030
01 Jul 2024
Pharma & Healthcare
Meningococcal Group A and C Conjugate Vaccine
The global Meningococcal Group A and C Conjugate Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Haemophilus Influenzae Type b Conjugate Vaccine Supply, Demand and Key Producers, 2024-2030
15 Feb 2024
Pharma & Healthcare
Haemophilus Influenzae Type b Conjugate Vaccine
The global Haemophilus Influenzae Type b Conjugate Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Conjugate Vaccine
Total: 25 records, 3 pages
According to our (Global Info Research) latest study, the global Conjugate Vaccine market size was valued at USD 10280 million in 2023 and is forecast to a readjusted size of USD 12700 million by 2030 with a CAGR of 3.1% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Pneumococcal Conjugate Vaccine (PCV) market size was valued at USD 4257.8 million in 2023 and is forecast to a readjusted size of USD 5258.8 million by 2030 with a CAGR of 3.1% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Haemophilus b Conjugate Vaccine (Hib) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
USD3480.00
Add To Cart
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global 13-Valent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Multivalent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Meningococcal Group A and C Conjugate Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
USD3480.00
Add To Cart
The global Meningococcal Group A and C Conjugate Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
The global Haemophilus Influenzae Type b Conjugate Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>